|
|
|
Insider
Information: |
Oren Dan |
Relationship: |
10% Owner |
City: |
Or Akiva |
State: |
L3 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
106,486,757 |
|
Indirect Shares
|
185,591,533 |
|
|
Direct
Value |
$1,135,391,790 |
|
|
Indirect Value
|
$1,565,464,674 |
|
|
Total
Shares |
292,078,290 |
|
|
Total
Value |
$2,700,856,464 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
Percentage
Gain/Loss : |
135.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Tekmira Pharmaceuticals Corp |
TKMR |
10% Owner |
|
0 |
2016-07-08 |
16,013,540 |
Premium* |
|
Sio Gene Therapies Inc |
SIOX |
10% Owner |
|
0 |
2019-03-18 |
105,952,381 |
Premium* |
|
Myovant Sciences Ltd. |
MYOV |
10% Owner |
|
0 |
2019-06-04 |
40,765,599 |
Premium* |
|
Urovant Sciences Ltd. |
UROV |
10% Owner |
2018-10-01 |
0 |
2019-06-19 |
22,860,013 |
Premium* |
|
Protalix Biotherapeutics |
PLX |
10% Owner |
2021-06-03 |
3,637,314 |
|
0 |
Premium* |
|
Roivant Sciences Ltd. |
ROIV |
10% Owner |
2022-11-10 |
102,849,443 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ROIV |
Roivant Sciences Ltd. |
10% Owner |
|
2022-11-10 |
4 |
B |
$5.00 |
$20,000,000 |
D/D |
4,000,000 |
102,849,443 |
2.45 |
% |
|
ROIV |
Roivant Sciences Ltd. |
10% Owner |
|
2022-04-25 |
4 |
B |
$3.91 |
$33,635 |
D/D |
8,600 |
98,849,443 |
2.37 |
% |
|
ROIV |
Roivant Sciences Ltd. |
10% Owner |
|
2022-04-22 |
4 |
B |
$3.83 |
$121,319 |
D/D |
31,685 |
98,840,843 |
2.45 |
% |
|
ROIV |
Roivant Sciences Ltd. |
10% Owner |
|
2021-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
98,809,158 |
|
- |
|
PLX |
Protalix Biotherapeutics |
10% Owner |
|
2021-06-03 |
4 |
S |
$2.25 |
$1,932,304 |
D/D |
(857,506) |
3,637,314 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
10% Owner |
|
2021-06-02 |
4 |
S |
$2.56 |
$156,553 |
D/D |
(61,211) |
4,494,820 |
0 |
- |
|
PLX |
Protalix Biotherapeutics |
10% Owner |
|
2021-02-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,556,031 |
|
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-19 |
4 |
AB |
$8.17 |
$40,495 |
I/I |
4,957 |
22,860,013 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-18 |
4 |
AB |
$8.21 |
$55,061 |
I/I |
6,706 |
22,855,056 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-17 |
4 |
AB |
$8.53 |
$55,825 |
I/I |
6,541 |
22,848,350 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-14 |
4 |
AB |
$7.91 |
$56,514 |
I/I |
7,144 |
22,841,809 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-13 |
4 |
AB |
$7.95 |
$58,543 |
I/I |
7,367 |
22,834,665 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-12 |
4 |
AB |
$8.30 |
$62,244 |
I/I |
7,500 |
22,827,298 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-11 |
4 |
AB |
$8.58 |
$61,694 |
I/I |
7,189 |
22,819,798 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-10 |
4 |
AB |
$8.35 |
$62,594 |
I/I |
7,500 |
22,812,609 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-07 |
4 |
AB |
$7.97 |
$52,959 |
I/I |
6,649 |
22,805,109 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-06 |
4 |
AB |
$8.00 |
$56,621 |
I/I |
7,082 |
22,798,460 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-05 |
4 |
AB |
$8.02 |
$52,418 |
I/I |
6,540 |
22,791,378 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-04 |
4 |
AB |
$7.59 |
$56,911 |
I/I |
7,500 |
22,784,838 |
0 |
- |
|
MYOV |
Myovant Sciences Ltd. |
10% Owner |
|
2019-06-04 |
4 |
B |
$8.25 |
$19,999,997 |
I/I |
2,424,242 |
40,765,599 |
1.5 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-06-03 |
4 |
AB |
$7.71 |
$41,815 |
I/I |
5,424 |
22,777,338 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-05-31 |
4 |
AB |
$7.70 |
$39,042 |
I/I |
5,071 |
22,771,914 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-05-30 |
4 |
AB |
$8.91 |
$2,672 |
I/I |
300 |
22,766,843 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-05-30 |
4 |
AB |
$7.97 |
$55,418 |
I/I |
6,951 |
22,766,543 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2019-05-29 |
4 |
AB |
$7.55 |
$51,983 |
I/I |
6,882 |
22,759,592 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|